CollPlant Ltd-Product Pipeline Analysis, 2017 Update

CollPlant Ltd-Product Pipeline Analysis, 2017 Update


  • Products Id :- GDME15401PD
  • |
  • Pages: 31
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

CollPlant Ltd (CollPlant) is a regenerative medicine company that develops and commercializes tissue repair products. The company's product categories include orthobiologics, wound care, and pipeline products. Its orthobiologics products comprise VergenixSTR and VergenixBVF. CollPlant's wound care products include VergenixFG, Vergenix wound dressing. Its pipeline includes bioink, VergenixTRA, and surgical wounds. CollPlant offers tissue repair products in the areas of orthopedic applications and for advanced wound healing. The company's products include a surgical matrix for spinal fusion and bone trauma, a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote a rapid optimal healing of acute and chronic wounds. It develops regenerative medicine by utilizing proprietary processing technologies based on recombinant human collagen and other proteins. CollPlant is headquartered in Ness Ziona, Israel.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company CollPlant Ltd

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

CollPlant Ltd Company Overview 4

CollPlant Ltd Company Snapshot 4

CollPlant Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

CollPlant Ltd-Pipeline Analysis Overview 7

CollPlant Ltd-Key Facts 7

CollPlant Ltd-Major Products and Services 8

CollPlant Ltd Pipeline Products by Development Stage 9

CollPlant Ltd Pipeline Products Overview 11

Absorbable Bio-active Surgical Matrix-Spinal Fusion 11

Absorbable Bio-active Surgical Matrix-Spinal Fusion Product Overview 11

Vergenix STR-Anterior Cruciate Ligament 12

Vergenix STR-Anterior Cruciate Ligament Product Overview 12

Vergenix STR-Rotator Cuff Repair 13

Vergenix STR-Rotator Cuff Repair Product Overview 13

Vergenix TRA 14

Vergenix TRA Product Overview 14

VergenixBVF 15

VergenixBVF Product Overview 15

VergenixBVF-Antibiotics 16

VergenixBVF-Antibiotics Product Overview 16

VergenixDMR 17

VergenixDMR Product Overview 17

VergenixHVR 18

VergenixHVR Product Overview 18

VergenixPBR 19

VergenixPBR Product Overview 19

CollPlant Ltd-Key Competitors 20

CollPlant Ltd-Key Employees 21

CollPlant Ltd-Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

CollPlant Ltd, Recent Developments 23

May 31, 2017: CollPlant Provides Operational Update for Q1 2017 23

May 22, 2017: CollPlant Extends its European Distribution Network With Signing of New Distribution Agreement in Turkey for VergenixFG Wound Treatment 23

May 11, 2017: CollPlant Establishes a Separate Division to Focus on 3D Bio-Printing of Organs and Tissues 24

Apr 11, 2017: CollPlant Reports Positive Results From Post-Marketing Surveillance of VergenixFG 24

Mar 30, 2017: CollPlant Provides Commercial and Operational Update 24

Nov 08, 2016: CollPlant Signs Exclusive Distribution Agreement with Arthrex for VergenixSTR 25

Oct 19, 2016: CollPlant Receives CE Mark for Vergenix STR for Treatment of Tendinopathy 25

Aug 17, 2016: CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix STR for Treatment of Tendinopathy 26

May 31, 2016: CollPlant Receives Chief Scientist's Authorization for a NIS 12 Million Research and Development Projects with Funding of Approximately 50% 27

Feb 23, 2016: CollPlant Receives CE Mark for VergenixFG Wound Filler 27

Appendix 28

Methodology 28

About GlobalData 30

Contact Us 30

Disclaimer 30

List of Figures

CollPlant Ltd Pipeline Products by Equipment Type 5

CollPlant Ltd Pipeline Products by Development Stage 9

List of Tables

CollPlant Ltd Pipeline Products and Ongoing Clinical Trials Overview 4

CollPlant Ltd Pipeline Products by Equipment Type 5

CollPlant Ltd Pipeline Products by Indication 6

CollPlant Ltd, Key Facts 7

CollPlant Ltd, Major Products and Services 8

CollPlant Ltd Number of Pipeline Products by Development Stage 9

CollPlant Ltd Pipeline Products Summary by Development Stage 10

Absorbable Bio-active Surgical Matrix-Spinal Fusion-Product Status 11

Absorbable Bio-active Surgical Matrix-Spinal Fusion-Product Description 11

Vergenix STR-Anterior Cruciate Ligament-Product Status 12

Vergenix STR-Anterior Cruciate Ligament-Product Description 12

Vergenix STR-Rotator Cuff Repair-Product Status 13

Vergenix STR-Rotator Cuff Repair-Product Description 13

Vergenix TRA-Product Status 14

Vergenix TRA-Product Description 14

VergenixBVF-Product Status 15

VergenixBVF-Product Description 15

VergenixBVF-Antibiotics-Product Status 16

VergenixBVF-Antibiotics-Product Description 16

VergenixDMR-Product Status 17

VergenixDMR-Product Description 17

VergenixHVR-Product Status 18

VergenixHVR-Product Description 18

VergenixPBR-Product Status 19

VergenixPBR-Product Description 19

CollPlant Ltd, Key Employees 21

Glossary 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

CollPlant Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53520
Site License
USD 1500 INR 107040
Corporate User License
USD 2250 INR 160560

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com